Topline data from the phase 3 E-BEOND and C-BEOND trials show a significant reduction in monthly migraine days at 24 weeks, demonstrating efficacy across the full migraine spectrum.

BC, presented ways in which artificial intelligence (AI) can be part of the solution to widespread burnout among NPs. Dr ...

Recompensation in alcohol-related hepatitis (AH) is relatively common, especially with alcohol abstinence, according to study findings published in Clinical Gastroenterology and H ...

Experts discuss the bidirectional relationship between financial toxicity and cardiovascular disease outcomes in the US ...

Researchers evaluated the efficacy of cannabinoid-based therapies for managing agitation and neuropsychiatric symptoms in Alzheimer disease.

Among patients with psoriasis or atopic dermatitis who had phenotype switching, Janus kinase inhibitors were the most commonly used treatments for therapy modification. Treatment-associated phenotype ...

Researchers evaluated the real-world efficacy of statewide doxycycline post-exposure prophylaxis against common sexually transmitted infections.

Online glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescription vendors frequently do not require clinician interaction, according to a research letter published online July 6 in the Journal ...

Chronic pain and cancer pain management require a multimodal approach that addresses physical, emotional, and spiritual ...

HealthDay News — Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is common people with eating disorders, according to a research letter published online June 24 in JAMA Psychiatry.